间质性肺病的姑息治疗:呼吸专科医师全国性调查
本研究对日本呼吸学会认证的3423名呼吸专科医师进行全国性自填式问卷调查,1332名(38.9%)完成问卷,分析其中1023名过去一年照护过间质性肺病(ILD)患者的医师数据。结果显示仅25%曾将ILD患者转介至姑息治疗团队,且医师在ILD症状缓解和决策方面较肺癌更感困难。
要点
- 仅25%的呼吸专科医师曾将ILD患者转介至姑息治疗团队。
- 医师在ILD的症状缓解和决策方面较肺癌更感困难。
- ILD特异性障碍包括无法预测预后、缺乏呼吸困难既定治疗等。
核心结论
- 呼吸专科医师在提供ILD姑息治疗时较肺癌更感困难,并报告了显著的ILD特异性障碍。
研究设计与样本
- 全国性自填式问卷调查,邮寄至日本呼吸学会认证的呼吸专科医师3423名。
- 1332名(38.9%)完成问卷,分析其中1023名过去一年照护过ILD患者的医师数据。
主要发现
- 多数参与者报告ILD患者经常或总是主诉呼吸困难和咳嗽,但仅25%曾将其转介至姑息治疗团队。
- 临终沟通的时机倾向于晚于医师认为的理想时机。
- 与肺癌相比,参与者报告在ILD姑息治疗中症状缓解和决策显著更困难。
- 与肺癌相比,ILD的呼吸困难阿片类药物处方较少。
- ILD特异性障碍包括无法预测预后、缺乏呼吸困难既定治疗、心理和社会支持短缺、患者/家属难以接受疾病不良预后。
临床怎么用
- 呼吸专科医师应关注ILD患者的姑息治疗需求,考虑及时转介姑息治疗团队。
- 针对ILD特异性障碍,需加强预后预测、呼吸困难治疗及心理社会支持。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: Interstitial lung disease (ILD) is progressive with high symptom burdens and poor prognosis. Patients with ILD need optimal palliative care to maintain their quality of life, however, few nationwide surveys have addressed palliative care for ILD. METHODS: A nationwide, self-administered questionnaire was conducted. Questionnaires were sent by mail to pulmonary specialists certified by the Japanese Respiratory Society (n = 3423). The current practices of PC for ILD, end-of-life communication, referral to a PC team, barriers to PC for ILD, and comparison of PC between ILD and lung cancer (LC). RESULTS: 1332 (38.9%) participants completed the questionnaire, and the data of 1023 participants who had cared for ILD patients in the last year were analysed. Most participants reported that ILD patients often or always complained of dyspnoea and cough, but only 25% had referred them to a PC team. The timing of end-of-life communication tended to be later than the physician-perceived ideal timing. The participants experienced significantly greater difficulty in symptomatic relief and decision-making in PC for ILD compared to LC. Prescription of opioids for dyspnoea was less frequent for ILD than for LC. ILD-specific barriers in PC included an 'inability to predict prognosis', 'lack of established treatments for dyspnoea', 'shortage of psychological and social support', and 'difficulty for patients/families to accept the disease's poor prognosis'. CONCLUSION: Pulmonary specialists experienced more difficulty in providing PC for ILD compared to LC and reported considerable ILD-specific barriers in PC. Multifaceted clinical studies are needed to develop optimal PC for ILD.
引用
- Fujisawa T, Akiyama N, Morita T, et al. Palliative care for interstitial lung disease: A nationwide survey of pulmonary specialists. Respirology. 2023. PMID: 36949008. doi:10.1111/resp.14493
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。